R.V. Paul Chan, MD, MSc, MBA is the Department Head and the John H. Panton, MD Professor of Ophthalmology at the Illinois Eye and Ear Infirmary, University of Illinois at Chicago (UIC). His clinical practice focuses on vitreoretinal surgery, with an expertise in pediatric retinal disease.

Dr. Chan received his BA from the University of Pennsylvania, his MD from the Temple University School of Medicine, MSc from Weill Cornell Medical College (WCMC), and MBA from the University of Chicago’s Booth School of Business. After completing Ophthalmology residency at the New York-Presbyterian Hospital of WCMC, he went on to a Fellowship in Vitreoretinal Surgery at the Massachusetts Eye and Ear Infirmary at Harvard Medical School. Dr. Chan spent nine years on faculty at WCMC, as Director of the Retina Service and Vitreoretinal Fellowship, before moving to UIC.

Dr. Chan previously served as the Vice Chair for both Clinical Affairs and Global Ophthalmology in the Department of Ophthalmology and Visual Sciences at UIC and is a global leader in pediatric blindness prevention and retinopathy of prematurity (ROP). His primary research interests focus on utilizing new technology and imaging techniques to better evaluate and manage children with retinal disease. He has authored more than 250 peer-reviewed articles and has received grant funding from the NIH, NSF, and charitable foundations. He served as a core team member of the Imaging and Informatics for ROP (i-ROP) consortium and leads the Global Education Network for ROP (GEN-ROP), which is an international collaboration of investigators with expertise in neonatology, ophthalmology, biomedical informatics, international health, and medical education. Together, they developed tele-education and telemedicine programs, and have established clinical, teaching, and research collaborations in Asia, Latin America, and Africa. Dr. Chan has also served as a consultant for programs sponsored by the United States Agency for International Development (USAID), Orbis International, and Helen Keller International (HKI).